Threoglucins as potent-antibacterial agents against streptococcus suis
AssigneeThe Trustees of Princeton University
InventorsMohammad R. Seyedsayamdost, Brett C. Covington, Kenzie A. Clark
Life of this patent
Estimating the term…
Abstract
Compositions are provided that can be used to, e.g., treat or prevent infections caused by Streptococcus suis. The compositions may include one or more threoglucins in a carrier, at a total concentration of threoglucins being at least 1 μM. The at least one threoglucin may include one or more of threoglucins A-R. Such threoglucins may be produced by, e.g., growing a culture of Streptococcus suis in the presence of niacin, nicotinamide, and/or anabasine.
Claims14
A composition for use in treating or preventing infections caused by Streptococcus suis, comprising at least one threoglucin in a carrier, the at least one threoglucin being present at a total concentration of at least 1 μM.
A pharmaceutical composition comprising at least one threoglucin in a pharmaceutically acceptable carrier, the at least one threoglucin being present at a total concentration of at least 1 μM.
A method for production of a threoglucin, comprising:
- growing a culture of Streptococcus suis in the presence of niacin, nicotinamide, and/or anabasine.
Dependencies are inferred from the claim text.